3,7-Dimethyloct-6-enal oxime
Common Name: |
3,7-Dimethyloct-6-enal oxime |
IUPAC Name: |
N-(3,7-dimethyloct-6-enylidene)hydroxylamine |
Molecular Formula: |
C10H19NO |
SMILES: |
CC(CCC=C(C)C)CC=NO |
Inchi: |
1S/C10H19NO/c1-9(2)5-4-6-10(3)7-8-11-12/h5,8,10,12H,4,6-7H2,1-3H3 |
Inchi Key: |
JUCCIEVMICHZPK-UHFFFAOYSA-N |
Cas No: |
22457-25-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
169.26 |
Mass (g/mol) |
169.147 |
Molar Refractivity |
54.12 |
Net Charge |
|
HBD |
1 |
HBA |
2 |
Rt Bonds |
5 |
Rings |
|
TPSA |
32.59 |
Hetero Atoms |
2 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
271.19 |
Vapor Pressure (mmHg@25.00 °C) |
0.002 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.70 |
LogP |
3.219 |
iLOGP |
2.33 |
XLOGP3 |
4.09 |
WLOGP |
3.22 |
MLOGP |
2.47 |
ESOL Log S |
-3.14 |
ESOL Solubility (mg/ml) |
0.124 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.48 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-1.91 |
Silicos-IT Solubility (mg/ml) |
2.1 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.43 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.717 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.002 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
0 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |